Your browser doesn't support javascript.
loading
The safety of lanreotide for neuroendocrine tumor.
Godara, Amandeep; Siddiqui, Nauman S; Byrne, Margaret M; Saif, Muhammad Wasif.
Afiliação
  • Godara A; a Gastrointestinal Oncology Program and Experimental therapeutics, Division of Hematology/Oncology , Tufts Medical Center - Tufts University School of Medicine , Boston , MA , USA.
  • Siddiqui NS; a Gastrointestinal Oncology Program and Experimental therapeutics, Division of Hematology/Oncology , Tufts Medical Center - Tufts University School of Medicine , Boston , MA , USA.
  • Byrne MM; a Gastrointestinal Oncology Program and Experimental therapeutics, Division of Hematology/Oncology , Tufts Medical Center - Tufts University School of Medicine , Boston , MA , USA.
  • Saif MW; a Gastrointestinal Oncology Program and Experimental therapeutics, Division of Hematology/Oncology , Tufts Medical Center - Tufts University School of Medicine , Boston , MA , USA.
Expert Opin Drug Saf ; 18(1): 1-10, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30582380

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Peptídeos Cíclicos / Neoplasias Gástricas / Somatostatina / Tumores Neuroendócrinos / Neoplasias Intestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Peptídeos Cíclicos / Neoplasias Gástricas / Somatostatina / Tumores Neuroendócrinos / Neoplasias Intestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2019 Tipo de documento: Article